237
Views
27
CrossRef citations to date
0
Altmetric
Original Article

Levocetirizine in persistent allergic rhinitis: continuous or on-demand use? A pilot study

, , , , , , , , , & show all
Pages 2829-2839 | Accepted 08 Aug 2008, Published online: 29 Aug 2008

References

  • Bousquet J, van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108 (5 Suppl):S147-334
  • Schoenwetter WF, Dupclay L, Appajosyula S,. et al. Economic impact and quality of life burden of allergic rhinitis. Curr Med Res Opin 2004;20:305-17
  • Blanc PD, Trupin L, Eisner M,. et al. The work impact of asthma and rhinitis: findings from a population-based survey. J Clin Epidemiol 2001;54:610-18
  • Bousquet J, Annesi-Maesano I, Carat F,. et al. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy 2005;35:728-32
  • Bousquet J, Neukirch F, Bousquet PJ,. et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 2006;117:158-62
  • Mösges R, Klimek L. Today's allergic rhinitis patients are different: new factors that may play a role. Allergy 2007;62:969-975
  • Passalacqua G, Ciprandi G, Pasquali M,. et al. An update on the asthma-rhinitis link. Curr Opin Allergy Clin Immunol. 2004; 4:177-83
  • Bachert C, van Cauwenberge P, Olbrecht J,. et al. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy 2006; 61:693-8
  • Bauchau V, Durham SR. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 2005; 60:350-3
  • Demoly P, Allaert F-A, Lecasble M,. et al. PRAGMA. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy 2003; 58:672-5
  • Ciprandi G, Buscaglia S, Pesce GP,. et al. Minimal persistent inflammation is present at mucosal level with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol 1995; 96:971-9
  • Ricca V, Landi M, Ferrero C,. et al. Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis. J Allergy Clin Immunol 2000; 105 (1 Pt 1):54-7
  • Strolin-Benedetti M, Plisnier M, Kaise J,. et al. Absorption, distribution, metabolism and excretion of [14C] levocetirizine, the R enantiomer of cetirizine, in healthy volunteers. Eur J Clin Pharmacol 2001; 57:571-82
  • Molimard M, Diquet B, Strolin Benedetti M. Comparison of pharmacokinetics and metabolism of desloratadine, fexofenadine, levocetirizine and mizolastine in humans. Fundam Clin Pharmacol 2004; 18:399-411
  • Gillard M, Benedetti MS, Chatelain P,. et al. Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines. Inflamm Res 2005; 54:367-9
  • Hair PI, Scott RJ. Levocetirizine: a review of its use in the management of allergic rhinitis and skin allergies. Drugs 2006; 66:973-96
  • Bachert C, Bousquet J, Canonica GW,. et al. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol 2004; 114:838-44
  • Canonica GW, Bousquet J, Van Hammee G,. et al. Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. Respir Med 2006; 100:1706-15
  • Baiardini I, Pasquali M, Giardini A,. et al. Rhinasthma: a new specific Qol Questionnaire for the subjects with rhinitis and asthma. Allergy 2003; 58:289-94
  • Ciprandi G, Pronzato C, Ricca V,. et al. Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in subjects with pollen allergy. Clin Exp Allergy 1995; 25:871-8
  • de Blic J, Wahn U, Billard E,. et al. Levocetirizine in children: evidenced efficacy and safety in a 6-week randomized seasonal allergic rhinitis trial. Pediatr Allergy Immunol 2005; 16:267-75
  • Potter PC. Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. Allergy 2003; 58:893-9
  • Potter PC. Efficacy and safety of levocetirizine on symptoms and health-related quality of life of children with perennial allergic rhinitis: a double-blind, placebo-controlled randomized clinical trial. Ann Allergy Asthma Immunol 2005; 95:175-80
  • Ciprandi G, Passalacqua G, Mincarini M,. et al. Continuous versus on demand treatment cetirizine for allergic rhinitis. Ann Allergy Asthma Immunol 1997; 79:507-11
  • Ciprandi G, Ricca V, Passalacqua G,. et al. Seasonal rhinitis and azelastine: long- or short-term treatment? J Allergy Clin Immunol 1997; 99:301-7
  • Ciprandi G, Marseglia GL, Klersy C,. et al. Relationships between allergic inflammation and nasal airflow in children with persistent allergic rhinitis due to mite sensitization. Allergy 2005; 60:957-60
  • Lauriello M, Muzi P, Di Rienzo L,. et al. A two-year course of specific immunotherapy or of continuous antihistamine treatment reverse eosinophilic inflammation in severe persistent allergic rhinitis. Acta Otorhinolaryngol Ital 2005; 25:284-91
  • Baiardini I, Brandi S, Braido F,. et al. Allergic diseases and their impact on quality of life. Ann Allergy Asthma Immunol 2006; 97:419-28
  • Stull DE, Roberts L, Frank L,. et al. Relationship of nasal congestion with sleep, mood, and productivity. Curr Med Res Opin 2007; 23:811-19
  • Pratt EL, Craig TJ. Assessing outcomes from the sleep disturbance associated with rhinitis. Curr Opin Allergy Clin Immunol 2007; 7:249-56
  • Klimek L, Bachert C, Canonica GW,. et al. Long-term treatment of persistent allergic rhinitis with levocetirizine: improvements in activity and sleep items of the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ). Allergy Clin Immunol Int – J World Allergy Org 2007; 19:4-10
  • Pasquali M, Baiardini I, Rogkakou A,. et al. Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. Clin Exp Allergy 2006; 36:1161-7
  • Ciebiada M, Górska-Ciebiada M, DuBuske LM,. et al. Montelukast with desloratadine or levocetirizine for the treatment of persistent allergic rhinitis. Ann Allergy Asthma Immunol 2006; 97:664-71

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.